NLK and Brain atrophy: Overexpression of NLK via adeno-associated virus (AAV) injection into the striatum of N171-82Q mice leads to decreased brain atrophy, increased dopamine- and cAMP-regulated neuronal phosphoprotein (DARPP32) expression and decreased mtHTT aggregates.